The diversity of chronic hepatitis B virus infections within blood donors in England and North Wales 2005 through 2010

Transfusion

Volumn 53, Issue 10 PART 2, 2013, Pages 2467-2476

  Rosenberg, Gillian K ^a   Lattimore, Sam ^a   Brailsford, Susan R ^a   Hewitt, Patricia E ^a   Tettmar, Kate I ^a   Kitchen, Alan D ^a   Ijaz, Samreen ^a   Tedder, Richard S ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BLOOD; BLOOD DONOR; CLASSIFICATION; EPIDEMIOLOGY; FEMALE; GENETIC VARIABILITY; GENETICS; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; MALE; STATISTICS; UNITED KINGDOM; VIROLOGY; HEPATITIS B, CHRONIC; STATISTICS AND NUMERICAL DATA;

ADULT; BLOOD DONORS; ENGLAND; FEMALE; GENETIC VARIATION; GENOTYPE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; SEROEPIDEMIOLOGIC STUDIES; WALES;

EID: 84891714403     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12003     Document Type: Article

References (33)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97-107.
2. Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004;350: 1118-29.
3. Brant LJ, Hurrelle M, Collins S, Klapper PE, Ramsay ME. Using automated extraction of hepatitis B tests for surveillance: evidence of decreasing incidence of acute hepatitis B in England. Epidemiol Infect 2012;140:1075-86.
4. Health Protection Agency. Migrant health: infectious diseases in non-UK born populations in England,Wales and Northern Ireland. A baseline report-2006. London: Health Protection Agency Centre for Infections; 2006.
5. NHS Blood and Transplant/Health Protection Agency. Safe supplies: focusing on epidemiology. Annual review from the NHS Blood and Transplant/Health Protection Agency Colindale Epidemiology Unit 2010. London. September 2011. [cited 2012 Nov 15]. Available from: URL: http://www.hpa.org.uk/webc/HPAwebFile/ HPAweb-C/1317130910492
6. James V, McClelland B. Guidelines for the blood transfusion services in the United Kingdom. London: The Stationery Office; 2005.
7. Brant LJ, Reynolds C, Byrne L, Davison KL. Hepatitis B and residual risk of infection in English andWelsh blood donors, 1996 through 2008. Transfusion 2011;51:1493-502.
8. O'Brien SF, Xi G, Fan W, Yi QL, Fearon MA, Scalia V, Goldman M. Epidemiology of hepatitis B in Canadian blood donors. Transfusion 2008;48:2323-30.
9. Polizzotto MN, Wood EM, Ingham H, Keller AJ. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006. Transfusion 2008;48:55-63.
10. Servant-Delmas A, Mercier M, El Ghouzzi MH, Girault A, Bouchardeau F, Pillonel J, Laperche S. National survey of hepatitis B virus (HBV) polymorphism in asymptomatic HBV blood donors from 1999 to 2007 in France. Transfusion 2010;50:2607-18.
11. Van der Bij AK, Coutinho RA, Van der Poel CL. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands. Transfusion 2006;46:1729-36.
12. Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol 2011;26 Suppl 1:123-30.
13. Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol 2009;15:5761-9.
14. McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int 2009;3:334-42.
15. Moerman B, Moons V, Sommer H, Schmitt Y, Stetter M. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab 2004;50:159-62.
16. Ly TD, Servant-Delmas A, Bagot S, Gonzalo S, Ferey MP, Ebel A, Dussaix E, Laperche S, Roque-Afonso AM. Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms. J Clin Microbiol 2006;44:2321-6.
17. Davidson F, Lycett C, Sablon E, Petrik J, Dow BC. Hepatitis B virus genotypes and precore mutations in Scottish blood donors. Vox Sang 2005;88:87-92.
18. Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet 2011;378:73-85.
19. Piccolo P, Lenci I, Telesca C, Di Paolo D, Bandiera F, De Melia L, Sorbello O, Renier G, Ricci GL, Nosotti L, Romano M, De Santis A, Levrero M, Antonucci G, Longo MA, Annicchiarico BE, Angelico M. Patterns of chronic hepatitis B in Central Italy: a cross-sectional study. Eur J Public Health 2010;20:711-3.
20. Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB. Evolving clinical landscape of chronic hepatitis B: a multicenter Italian study. J Med Virol 2009;81:1999-2006.
21. Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H. Virological and clinical characteristics of delta hepatitis in Central Europe. J Viral Hepat 2009;16: 883-94.
22. Genne D, Rossi I. Hepatitis delta in Switzerland: a silent epidemic. Swiss Med Wkly 2011;141:w13176.
23. Garson JA, Grant PR, Ayliffe U, Ferns RB, Tedder RS. Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control. J Virol Methods 2005;126: 207-13.
24. Ijaz S, Arnold C, Dervisevic S, Mechurova J, Tatman N, Tedder RS, Naoumov NV. Dynamics of lamivudineresistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy. J Med Virol 2008;80:1160-70.
25. Karatayli E, Karayalcin S, Karaaslan H, Kayhan H, Turkyilmaz AR, Sahin F, Yurdaydin C, Bozdayi AM. A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment. Antivir Ther 2007;12:761-8.
26. Locarnini S. Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure. Hepatol Int 2008;2:147-51.
27. Kramvis A, Kew M, Francois G. Hepatitis B virus genotypes. Vaccine 2005;23:2409-23.
28. Friedt M, Gerner P, Lausch E, Trubel H, Zabel B, Wirth S. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology 1999; 29:1252-8.
29. Utama A, Siburian MD, Purwantomo S, Intan MD, Kurniasih TS, Gani RA, Achwan WA, Arnelis, Lelosutan SA, Lukito B, Harmono T, Zubir N, Julius, Soemohardjo S, Lesmana LA, Sulaiman A, Tai S. Association of core promoter mutations of hepatitis B virus and viral load is different in HBeAg(+) and HBeAg(-) patients. World J Gastroenterol 2011;17:708-16.
30. Fan W, Shi B, Wei H, Du G, Song S. Comparison of hepatitis B X gene mutation between patients with hepatocellular carcinoma and patients with chronic hepatitis B. Virus Genes 2011;42:162-70.
31. Arankalle VA, Gandhi S, Lole KS, Chadha MS, Gupte GM, Lokhande MU. An outbreak of hepatitis B with high mortality in India: association with precore, basal core promoter mutants and improperly sterilized syringes. J Viral Hepat 2011;18:e20-8.
32. Delwart E, Slikas E, Stramer SL, Kamel H, Kessler D, Krysztof D, Tobler LH, Carrick DM, Steele W, Todd D, Wright DJ, Kleinman SH, Busch MP. Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. J Infect Dis 2012; 205:875-85.
33. Kitchen AD, Barbara JA, Hewitt PE. Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines. Vox Sang 2005;89:77-80.